Breast Cancer
Power3 Medical Products, Inc. Provides Results from 60 Patient Blinded Validation Study of BC-SeraPro
Published in Cancer Weekly, August 14th, 2007
For the study, Power3 used its extensive patient serum sample bank to generate a statistical model that differentiates between breast cancer and control profiles. Sixty blinded patient samples were then tested against this statistical model. The samples were provided by Mercy Women's Center under the direction of Dr. Alan Hollingsworth, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-08-14)
More Articles from Cancer Weekly
- Brain Cancer
Peregrine Pharmaceuticals Doses First Patient in Cotara Phase II Brain Cancer Trial In India - Breast Cancer
Biofield Signs Master License Agreement with the MacKay Group to Distribute, Manufacture, Develop and Commercialize the Biofield Breast Cancer Diagnostic System (BDS) - Breast Cancer
Chicagoland Affiliate of Susan G. Komen for the Cure, State Lawmakers, Breast Cancer Survivors, Faith Leaders Rally for Action on Breast Cancer - Breast Cancer
Hooters Donates $250,000 to the V Foundation for Cancer Research Towards Kelly Jo Dowd Breast Cancer Research Grant - Breast Cancer
National Breast Cancer Foundation Unveils Innovative Web Site for Survivors - Breast Cancer
Susan G. Komen for the Cure Announces Chief Financial Officer, Vice President of Health Sciences, Associate General Counsel - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
